Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
425.73
-6.27 (-1.45%)
At close: Nov 6, 2026, 4:00 PM EST
425.62
-0.11 (-0.03%)
After-hours: Nov 6, 2026, 4:00 PM EST
Elevance Health Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, Elevance Health stock has a consensus rating of "Buy" and an average price target of $482.38. The average 1-year stock price forecast is 13.31% higher than the current stock price, while the lowest is $406 (-4.63%) and the highest is $523 (+22.85%).
Price Target: $482.38 (+13.31%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Elevance Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 12 | 12 |
| Buy | 3 | 2 | 3 | 3 | 2 | 3 |
| Hold | 7 | 8 | 7 | 7 | 8 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 22 | 22 | 22 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bernstein | Bernstein | Buy Maintains $488 → $520 | Buy | Maintains | $488 → $520 | +22.14% | Nov 4, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $473 → $492 | Buy | Reiterates | $473 → $492 | +15.57% | Oct 27, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $465 → $495 | Buy | Maintains | $465 → $495 | +16.27% | Oct 23, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $470 → $490 | Buy | Maintains | $470 → $490 | +15.10% | Oct 23, 2026 |
Scott Fidel Goldman Sachs | Goldman Sachs | Hold Maintains $395 → $451 | Hold | Maintains | $395 → $451 | +5.94% | Oct 23, 2026 |
Financial Forecast
Revenue This Year
198.85B
from 199.13B
Decreased by -0.14%
Revenue Next Year
203.75B
from 198.85B
Increased by 2.46%
EPS This Year
29.14
from 30.29
Decreased by -3.80%
EPS Next Year
30.30
from 29.14
Increased by 3.98%
EPS and Forward PE are based on non-GAAP adjusted numbers.